drugset
drugset / Trial / NCT03472547

A Study of Sensitizing Potential of Diacerein 1% Ointment in Healthy Subjects

NCT03472547 ↗

Phase 1 Completed 234 enrolled Castle Creek Pharmaceuticals, LLC
NaSingle-groupOpen-labelOther

Summary

Single center, randomized, controlled, evaluator blinded, within-subject study to evaluate the sensitization potential of diacerein 1% ointment under occlusive conditions on normal skin of healthy volunteer subjects.

Timeline

Start
2018-01-15
Primary completion
2018-03-03
Completion
2018-03-03

Drugs

EvaluationDrugModalityDoseRoute
Subject Diacerein Small molecule 1 % Topical

Indications

No indication recorded.